Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Increasing salesforce effectiveness

May 11, 2005 Sales and Marketing

Pfizer will cut costs worth $4 billion over the next three years in an attempt to return to double-digit earnings …
Feature

10 Brand Blunders…And How to Avoid Them

May 10, 2005 Sales and Marketing

1) Stay loyal to the core brand message and never undermine itIt may have seemed a good idea at the …
Feature

Stepping out: the contract salesforce

May 10, 2005 Sales and Marketing

Sales forces in the pharmaceutical industry account for around 75% of marketing budgets, and are coming under increasing pressure to …
Feature

Gilmartin to leave troubled Merck

May 6, 2005 Sales and Marketing

Raymond Gilmartin has stood down as chief executive and chairman of Merck, drawing a line under long-running uncertainty regarding the …
News

GSK makes strategic biotech acquisition

May 6, 2005 Research and Development, Sales and Marketing GSK, biotech

 GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …
News

Crestor sales top $1 billion for AstraZeneca

May 6, 2005 Sales and Marketing

AstraZeneca's Crestor has achieved blockbuster status, despite continuing concerns over its safety, registering sales of over $1 billion for the …
News

Lilly’s first-in-class diabetes drug approved in US

May 5, 2005 Sales and Marketing

Lilly has gained US marketing approval for Byetta, the first in a new class of type II diabetes treatments derived …
News

Mixed news for AstraZeneca’s stroke drug Cerovive

May 4, 2005 Research and Development, Sales and Marketing

AstraZeneca has received a boost from its phase III drug Cerovive, with clinical trial data showing the treatment can reduce …
News

Does your brand need a check-up?

May 4, 2005 Sales and Marketing

Brands are all about 'adding value'. To provide this value to our target customers we need to ensure we have …
Feature

Taking on the market leader

May 4, 2005 Sales and Marketing

Launching a new product into a therapeutic area dominated by a 'gold standard' doctors' favourite is a tough task but …
Feature

Velcade moves up to second line treatment

April 28, 2005 Sales and Marketing

Ortho Biotech's Velcade has received approval as a second-line treatment for patients with multiple myeloma in Europe, advancing it from …
News

EMEA advises against prescribing of antidepressants in children

April 28, 2005 Sales and Marketing

Doctors across Europe will be discouraged from prescribing most modern antidepressants for children and adolescents following new EMEA advice.Investigations into …
News

Cholesterol drugs boost Schering-Plough

April 26, 2005 Sales and Marketing

News

Strattera sales fall back over continuing safety concerns

April 26, 2005 Sales and Marketing

Lilly say it expects sales of Strattera to fall in 2005 because of continuing concerns over the safety of ADHD …
News

MHRA failing patients, warns report

April 26, 2005 Sales and Marketing

MPs have called for an urgent review of the UK drugs regulator, saying that tougher regulation of the industry is …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025